We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.76B
AUM Growth
-$525M
Cap. Flow
-$439M
Cap. Flow %
-15.9%
Top 10 Hldgs %
38.29%
Holding
343
New
69
Increased
54
Reduced
100
Closed
111

Top Buys

Rank Stock Value
1
VRAY
ViewRay, Inc.
VRAY
+$17.9M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$17.3M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$14.1M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$14M
5
CUTR
Cutera, Inc.
CUTR
+$12.7M

Top Sells

Rank Stock Value
1
SEER icon
Seer Inc
SEER
+$24.7M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.4M
3
LIVN icon
LivaNova
LIVN
+$20.2M
4
GKOS icon
Glaukos
GKOS
+$17.5M
5
COO icon
Cooper Companies
COO
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 29.75%
2 Consumer Staples 0.58%
3 Financials 0.5%
4 Consumer Discretionary 0.42%
5 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCPH
201
PUT
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$642K 0.02%
65,700
+52,100
+383% +$980K
CRBU icon
202
Caribou Biosciences
CRBU
$169M
$633K 0.02%
41,932
-1,707
-4% -$33.2K
CMPS
203
CALL
Compass Pathways
CMPS
$1.97B
$625K 0.02%
28,300
-120,400
-81% -$3.83M
PSTX
204
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$612K 0.02%
89,886
-24,457
-21% -$167K
WVE icon
205
Wave Life Sciences
WVE
$1.03B
$609K 0.02%
+194,106
New +$806K
AVEO
206
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$579K 0.02%
123,416
-24,158
-16% -$150K
KALV
207
DELISTED
KalVista Pharmaceuticals
KALV
$544K 0.02%
41,087
+19,139
+87% +$305K
INSM icon
208
Insmed
INSM
$28.9B
$537K 0.02%
+19,713
New +$564K
LOGC
209
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$532K 0.02%
230,121
-15,371
-6% -$52K
QNCX icon
210
PUT
Quince Therapeutics
QNCX
$31.8M
$490K 0.02%
194
-12
-6% -$73.2K
ELVN icon
211
Enliven Therapeutics
ELVN
$4.24B
$440K 0.02%
+48,884
New +$641K
CTMX icon
212
CytomX Therapeutics
CTMX
$760M
$420K 0.02%
96,905
-2,466
-2% -$14.4K
ROIVW
213
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$409K 0.01%
+199,648
New +$305K
BGMS
214
Bio Green Med Solution Inc
BGMS
$5.1M
$398K 0.01%
28
-1
-3% -$16.1K
IPHA
215
Innate Pharma
IPHA
$232M
$364K 0.01%
79,896
-2,613
-3% -$13.9K
RLMD icon
216
Relmada Therapeutics
RLMD
$503M
$333K 0.01%
+14,785
New +$329K
ISEE
217
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$328K 0.01%
19,600
-600
-3% -$9.83K
GYRE icon
218
Gyre Therapeutics
GYRE
$706M
$326K 0.01%
47,574
-2,104
-4% -$36K
ARDX icon
219
Ardelyx
ARDX
$1.03B
$253K 0.01%
+229,916
New +$273K
LQDA icon
220
Liquidia Corp
LQDA
$7.01B
$250K 0.01%
+51,404
New +$205K
TCACU
221
DELISTED
Tuatara Capital Acquisition Corporation Unit
TCACU
$201K 0.01%
20,000
– –
ACIU icon
222
AC Immune
ACIU
$267M
$168K 0.01%
33,997
-1,003
-3% -$5.83K
MTCR
223
DELISTED
Metacrine, Inc. Common Stock
MTCR
$133K ﹤0.01%
+197,130
New +$352K
ACHV icon
224
Achieve Life Sciences
ACHV
$687M
$127K ﹤0.01%
+16,325
New +$128K
SVRA icon
225
Savara
SVRA
$1.17B
$117K ﹤0.01%
94,414
-3,047
-3% -$3.63K
7 8
9
10 11

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Pura Vida Investments held 343 positions worth $2.76B, down 16% from $3.29B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $439M in Q4 2021, closing 111 positions and reducing 100 holdings. Its most notable exit was Seer Inc, an estimated $24.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Pura Vida Investments opened a new position in BioMarin Pharmaceuticals worth $15M.

  • Pura Vida Investments's largest Q4 2021 buy was BioMarin Pharmaceuticals: 170,210 shares worth $15M.
  • Pura Vida Investments added most to ViewRay, Inc. in Q4 2021, an estimated $17.9M increase.
  • Pura Vida Investments's biggest Q4 2021 reduction was LivaNova, cutting an estimated $20.2M.
  • Pura Vida Investments fully exited Seer Inc in Q4 2021, selling an estimated $24.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $2.76B portfolio in Q4 2021.
  • Pura Vida Investments opened 69 new positions and closed 111 in Q4 2021.
  • Pura Vida Investments's portfolio value fell 16% quarter-over-quarter to $2.76B.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.